BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming November 17, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Cytokinetics, Incorporated ("Cytokinetics†or the "Company†) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CYTOKINETICS, INCORPORATED (CYTK), CONTACT THE LAW OFFICES OF HOWARD G. SMITH. ...

诉讼核心信息 - Kahn Swick & Foti, LLC (KSF) 提醒投资者，针对 Cytokinetics, Incorporated (CYTK) 的证券集体诉讼的首席原告申请截止日期为 2025年11月17日 [1] - 诉讼适用于在 2023年12月27日至 2025年5月6日期间购买或收购公司证券的投资者 [1] - 该诉讼案件正在美国加州北区地方法院审理中 [1] 诉讼指控内容 - Cytokinetics 及其部分高管被指控在集体诉讼期间未能披露重大信息，违反了联邦证券法 [3] - 2025年3月10日，公司披露美国食品药品监督管理局决定不就其aficamten产品的新药申请召开咨询委员会会议 [4] - 2025年5月6日，公司披露其与FDA举行了多次新药申请前会议，讨论安全监测和风险缓解，但选择在没有风险评估和缓解策略的情况下提交新药申请，转而依赖标签和自愿性教育材料 [4] 市场影响与案件细节 - 受相关消息影响，Cytokinetics 股价下跌，于2025年5月7日收于每股33.04美元 [5] - 案件名称为 Seidman 诉 Cytokinetics, Incorporated 等人，案件编号 25-cv-07923 [5]

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cytokinetics investors who were adversely affected by alleged securities fraud between December 27, 2023 and May 6, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/cytokine ...

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Cytokinetics, Incorporated (CYTK) Investors To Inquire About Securities Fraud Class Action. ...

NEW YORK , Sept. 22, 2025 /PRNewswire/ -- Attorney Advertising --Â Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) and certain of its officers. ...

NEW YORK , Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK). ...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cytokinetics investors who were adversely affected by alleged securities fraud between December 27, 2023 and May 6, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/cytokine ...

集体诉讼概况 - 集体诉讼代表在2023年12月27日至2025年5月6日期间购买或收购Cytokinetics公司证券的个人和实体提起 [1] - 股东若希望作为首席原告，必须在2025年11月17日前向法院提交文件 [3] 指控核心内容 - 指控称，被告在公司新药申请提交和审批时间表方面做出了重大虚假和误导性陈述 [2] - 公司曾表示基于2025年9月26日的PDUFA日期，预计其新药aficamten将在2025年下半年获得美国FDA批准 [2] - 公司未能披露其未能提交风险评估与减灾策略可能延迟监管审批程序的重大风险 [2]

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Cytokinetics, Incorporated ("Cytokinetics†or the "Company†) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusive (the "Class Period†). Cytokinetics investors have until November 17, 2025 to file a lead plaintiff motion. IF YOU SUF. ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 Â (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept. ...